Gland Pharma, 543245, GLAND Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

29,677.57
35.03
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

27,229.19
1.00%
3.02

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.81
10.16
15.72

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.13
-0.52
4.37

PAT CAGR (%)

10 Years
5 Years
3 Years

13.26
-6.87
-3.65

P:E (Median)

8 Years
5 Years
3 Years

-
38.86
38.80

P:BV (Average)

8 Years
5 Years
3 Years

-
4.38
3.17

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
21.13
17.63

Earnings Forecasts:

(Updated: 21-02-2026)

Description 2024 2025 2026 2027
Adj EPS 42.4 57.12 71.56 85.66
P/E Ratio 42.51 31.55 25.19 21.04
Revenue 5583.63 6345.94 7188.04 8107.22
EBITDA 1268.92 1534.09 1845.09 2142.69
Net Income 698.53 916.73 1147.54 1376.08
ROA 6.38 8.56 9.89 10.11
P/B Ratio 3.25 3.01 2.75 2.47
ROE 7.82 9.86 11.45 12.63
FCFF 656.09 364.72 653.19 814.73
FCFF Yield 2.34 1.3 2.33 2.91
Net Debt -2242.48 -2529.37 -3175.88 -4054
BVPS 555.41 598 656.06 729.4

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 1,177.51 1,010.78 16.50% 1,074.15 1,062.99 1.05% 1,038.84 1,012.02 2.65% 1,030.35 1,174.83 -12.30%
Expenses 755.89 619.64 21.99% 699.26 699.19 0.01% 679.99 718.47 -5.36% 636.23 742.00 -14.25%
EBITDA 421.63 391.14 7.80% 374.89 363.80 3.05% 358.85 293.55 22.24% 394.12 432.83 -8.94%
EBIDTM 35.81% 38.70% 34.90% 34.22% 34.54% 29.01% 38.25% 36.84%
Other Income 60.21 65.06 -7.45% 82.59 57.80 42.89% 54.74 48.49 12.89% 43.72 46.95 -6.88%
Interest 0.50 18.31 -97.27% 3.97 0.17 2,235.29% 7.43 0.91 716.48% 3.45 4.53 -23.84%
Depreciation 44.53 43.77 1.74% 44.84 41.61 7.76% 43.77 40.82 7.23% 43.07 42.56 1.20%
PBT 412.46 394.13 4.65% 408.67 379.82 7.60% 362.38 300.31 20.67% 391.32 432.69 -9.56%
Tax 104.61 99.01 5.66% 106.68 98.11 8.74% 93.13 77.39 20.34% 101.32 111.28 -8.95%
PAT 307.85 295.12 4.31% 302.00 281.71 7.20% 269.26 222.92 20.79% 290.00 321.41 -9.77%
PATM 26.14% 29.20% 28.11% 26.50% 25.92% 22.03% 28.15% 27.36%
EPS 18.68 17.91 4.30% 18.32 17.09 7.20% 16.34 13.53 20.77% 17.60 19.50 -9.74%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 1,695.36 1,384.05 22.49% 1,486.88 1,405.83 5.77% 1,505.62 1,401.71 7.41% 1,424.91 1,537.45 -7.32%
Expenses 1,260.49 1,024.10 23.08% 1,172.99 1,108.78 5.79% 1,137.86 1,137.31 0.05% 1,077.39 1,178.80 -8.60%
EBITDA 434.88 359.96 20.81% 313.89 297.06 5.67% 367.76 264.40 39.09% 347.52 358.65 -3.10%
EBIDTM 25.65% 26.01% 21.11% 21.13% 24.43% 18.86% 24.39% 23.33%
Other Income 63.17 58.49 8.00% 84.16 59.66 41.07% 57.53 51.43 11.86% 44.03 42.15 4.46%
Interest 3.93 22.82 -82.78% 7.82 6.11 27.99% 11.50 5.62 104.63% 7.45 9.96 -25.20%
Depreciation 107.65 96.33 11.75% 106.31 93.83 13.30% 101.05 91.96 9.88% 95.76 92.61 3.40%
PBT 362.13 299.30 20.99% 283.92 256.78 10.57% 312.74 218.24 43.30% 288.33 298.23 -3.32%
Tax 100.65 94.61 6.38% 100.23 93.25 7.49% 97.26 74.48 30.59% 101.79 105.81 -3.80%
PAT 261.48 204.69 27.74% 183.68 163.53 12.32% 215.48 143.76 49.89% 186.54 192.42 -3.06%
PATM 15.42% 14.79% 12.35% 11.63% 14.31% 10.26% 13.09% 12.52%
EPS 15.87 12.42 27.78% 11.15 9.93 12.29% 13.08 8.73 49.83% 11.32 11.68 -3.08%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 4,320.85 4,116.15 4,167.43 3,616.53 4,400.71 3,462.88 2,633.24 2,044.20 1,619.94 1,479.18 1,347.87 Net Sales Growth 1.41% -1.23% 15.23% -17.82% 27.08% 31.51% 28.82% 26.19% 9.52% 9.74% Cost Of Goods Sold 1,715.58 1,730.60 1,820.31 1,685.42 2,109.22 1,219.00 836.07 626.35 479.75 375.07 540.21 Gross Profit 2,605.27 2,385.55 2,347.12 1,931.10 2,291.49 2,243.88 1,797.18 1,417.85 1,140.18 1,104.11 807.66 GP Margin 60.30% 57.96% 56.32% 53.40% 52.07% 64.80% 68.25% 69.36% 70.38% 74.64% 59.92% Total Expenditure 2,771.37 2,673.53 2,758.65 2,597.98 2,890.07 2,160.61 1,677.77 1,337.89 1,084.84 854.19 845.63 Power & Fuel Cost - 120.38 117.19 124.84 95.05 74.58 78.50 74.03 60.35 49.24 46.96 % Of Sales - 2.92% 2.81% 3.45% 2.16% 2.15% 2.98% 3.62% 3.73% 3.33% 3.48% Employee Cost - 439.02 409.94 399.70 338.57 311.36 277.66 222.95 179.08 153.42 131.30 % Of Sales - 10.67% 9.84% 11.05% 7.69% 8.99% 10.54% 10.91% 11.05% 10.37% 9.74% Manufacturing Exp. - 222.18 218.95 194.21 179.85 436.84 391.88 337.81 269.23 217.13 72.95 % Of Sales - 5.40% 5.25% 5.37% 4.09% 12.61% 14.88% 16.53% 16.62% 14.68% 5.41% General & Admin Exp. - 98.95 109.27 119.02 93.79 58.62 57.77 47.00 78.76 42.74 32.91 % Of Sales - 2.40% 2.62% 3.29% 2.13% 1.69% 2.19% 2.30% 4.86% 2.89% 2.44% Selling & Distn. Exp. - 23.31 34.66 30.26 40.98 36.69 17.08 13.88 9.93 11.40 15.80 % Of Sales - 0.57% 0.83% 0.84% 0.93% 1.06% 0.65% 0.68% 0.61% 0.77% 1.17% Miscellaneous Exp. - 39.10 48.31 44.53 32.61 23.51 18.82 15.86 7.73 5.19 15.80 % Of Sales - 0.95% 1.16% 1.23% 0.74% 0.68% 0.71% 0.78% 0.48% 0.35% 0.41% EBITDA 1,549.49 1,442.62 1,408.78 1,018.55 1,510.64 1,302.27 955.47 706.31 535.10 624.99 502.24 EBITDA Margin 35.86% 35.05% 33.80% 28.16% 34.33% 37.61% 36.28% 34.55% 33.03% 42.25% 37.26% Other Income 241.26 215.07 166.67 240.46 223.94 134.78 139.17 85.56 48.79 33.56 36.76 Interest 15.35 22.84 7.84 7.41 5.24 3.41 7.18 3.56 4.13 6.39 16.42 Depreciation 176.21 169.27 162.11 146.74 110.30 98.78 94.59 81.96 78.21 74.15 63.46 PBT 1,574.83 1,465.59 1,405.50 1,104.86 1,619.04 1,334.85 992.87 706.36 501.56 578.01 459.11 Tax 405.74 375.83 362.17 272.58 406.89 337.85 220.01 234.45 180.45 164.28 145.51 Tax Rate 25.76% 25.64% 25.77% 26.00% 25.13% 25.31% 22.16% 34.16% 35.98% 28.42% 31.69% PAT 1,169.11 1,089.75 1,043.33 775.83 1,212.15 997.00 772.86 451.91 321.11 413.73 313.61 PAT before Minority Interest 1,169.11 1,089.75 1,043.33 775.83 1,212.15 997.00 772.86 451.91 321.11 413.73 313.61 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 27.06% 26.47% 25.04% 21.45% 27.54% 28.79% 29.35% 22.11% 19.82% 27.97% 23.27% PAT Growth 4.28% 4.45% 34.48% -36.00% 21.58% 29.00% 71.02% 40.73% -22.39% 31.93% EPS 70.94 66.13 63.31 47.08 73.55 60.50 46.90 27.42 19.48 25.10 19.03

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Net Sales 6,112.77 5,616.50 5,664.72 3,624.60 4,400.71 3,462.88 2,633.24 Net Sales Growth 6.70% -0.85% 56.29% -17.64% 27.08% 31.51% Cost Of Goods Sold 2,139.55 2,090.38 2,173.09 1,685.42 2,109.22 1,219.00 836.07 Gross Profit 3,973.22 3,526.12 3,491.63 1,939.17 2,291.49 2,243.88 1,797.18 GP Margin 65.00% 62.78% 61.64% 53.50% 52.07% 64.80% 68.25% Total Expenditure 4,648.73 4,347.58 4,331.65 2,599.84 2,890.56 2,160.65 1,677.77 Power & Fuel Cost - 199.15 229.99 124.84 95.05 74.58 78.50 % Of Sales - 3.55% 4.06% 3.44% 2.16% 2.15% 2.98% Employee Cost - 1,401.56 1,256.89 403.26 338.57 311.36 277.66 % Of Sales - 24.95% 22.19% 11.13% 7.69% 8.99% 10.54% Manufacturing Exp. - 347.18 327.19 194.23 179.85 436.84 391.88 % Of Sales - 6.18% 5.78% 5.36% 4.09% 12.61% 14.88% General & Admin Exp. - 206.62 217.36 120.53 94.28 58.66 57.77 % Of Sales - 3.68% 3.84% 3.33% 2.14% 1.69% 2.19% Selling & Distn. Exp. - 27.48 37.46 27.03 40.98 36.69 17.08 % Of Sales - 0.49% 0.66% 0.75% 0.93% 1.06% 0.65% Miscellaneous Exp. - 75.20 89.66 44.53 32.61 23.51 18.82 % Of Sales - 1.34% 1.58% 1.23% 0.74% 0.68% 0.71% EBITDA 1,464.05 1,268.92 1,333.07 1,024.76 1,510.15 1,302.23 955.47 EBITDA Margin 23.95% 22.59% 23.53% 28.27% 34.32% 37.61% 36.28% Other Income 248.89 213.61 170.24 240.46 223.94 134.78 139.17 Interest 30.70 42.00 26.20 7.45 5.24 3.41 7.18 Depreciation 410.77 377.87 344.57 146.74 110.30 98.78 94.59 PBT 1,247.12 1,062.66 1,132.54 1,111.04 1,618.55 1,334.81 992.87 Tax 399.93 364.13 360.08 273.54 406.89 337.85 220.01 Tax Rate 32.07% 34.27% 31.79% 25.94% 25.14% 25.31% 22.16% PAT 847.18 698.53 772.46 781.04 1,211.66 996.96 772.86 PAT before Minority Interest 847.18 698.53 772.46 781.04 1,211.66 996.96 772.86 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.86% 12.44% 13.64% 21.55% 27.53% 28.79% 29.35% PAT Growth 20.27% -9.57% -1.10% -35.54% 21.54% 29.00% EPS 51.41 42.39 46.87 47.39 73.52 60.50 46.90

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 9,755.10 8,995.29 7,953.30 7,158.23 5,903.28 3,646.24 2,862.11 2,410.42 2,089.81 1,677.07 Share Capital 16.48 16.47 16.47 16.43 16.36 15.49 15.49 15.49 15.49 15.49 Total Reserves 9,738.57 8,977.43 7,935.16 7,128.56 5,861.51 3,614.26 2,846.62 2,394.93 2,074.32 1,661.57 Non-Current Liabilities 142.75 131.60 89.68 93.97 80.31 80.78 127.79 139.37 130.55 121.95 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 50.17 Unsecured Loans 1.11 2.55 3.26 3.82 3.93 4.07 4.96 5.49 5.92 6.37 Long Term Provisions 22.84 20.69 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 523.76 414.20 730.20 581.94 512.46 359.02 532.68 378.55 253.38 287.29 Trade Payables 385.87 281.19 589.42 462.76 396.28 249.09 446.20 292.42 189.29 88.51 Other Current Liabilities 88.03 100.94 109.46 76.42 62.36 81.73 72.60 71.13 61.87 151.77 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 39.90 Short Term Provisions 49.87 32.07 31.32 42.75 53.82 28.20 13.88 15.01 2.23 7.12 Total Liabilities 10,421.61 9,541.09 8,773.18 7,834.14 6,496.05 4,086.04 3,522.58 2,928.34 2,473.74 2,086.31 Net Block 1,744.99 1,693.73 1,570.55 1,502.19 954.23 968.10 928.74 842.64 871.58 787.88 Gross Block 2,798.04 2,579.91 2,294.95 2,081.32 1,430.70 1,347.81 1,219.58 1,054.45 1,005.52 1,020.22 Accumulated Depreciation 1,053.05 886.18 724.41 579.13 476.46 379.71 290.83 211.81 133.94 232.34 Non Current Assets 4,654.65 4,969.76 1,884.84 1,989.70 1,372.99 1,239.75 1,165.13 1,077.36 1,065.60 1,014.41 Capital Work in Progress 42.20 120.00 177.22 190.75 337.81 188.47 123.16 198.88 161.15 202.10 Non Current Investment 2,789.57 2,385.74 8.16 8.16 0.55 0.00 0.00 0.00 0.00 0.17 Long Term Loans & Adv. 77.89 114.38 128.92 286.40 77.97 81.52 111.89 33.89 29.42 21.63 Other Non Current Assets 0.00 655.91 0.00 2.21 2.43 1.66 1.33 1.95 3.44 2.62 Current Assets 5,766.96 4,571.32 6,888.34 5,844.44 5,123.07 2,846.29 2,357.46 1,850.98 1,408.15 1,071.90 Current Investments 0.00 0.00 0.00 154.87 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 1,254.23 1,260.21 1,945.30 1,185.67 1,275.17 756.28 911.88 512.83 378.72 367.08 Sundry Debtors 1,142.90 1,171.40 862.84 1,074.81 670.97 601.78 506.10 475.21 417.87 350.69 Cash & Bank 2,432.62 1,598.55 3,767.00 3,085.80 3,005.20 1,325.19 753.35 670.84 533.08 273.23 Other Current Assets 937.21 104.76 90.83 96.75 171.72 163.03 186.13 192.10 78.48 80.91 Short Term Loans & Adv. 810.85 436.41 222.37 246.55 87.60 91.80 131.94 126.45 30.20 36.37 Net Current Assets 5,243.20 4,157.13 6,158.14 5,262.50 4,610.61 2,487.27 1,824.78 1,472.43 1,154.77 784.61 Total Assets 10,421.61 9,541.08 8,773.18 7,834.14 6,496.06 4,086.04 3,522.59 2,928.34 2,473.75 2,086.31

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 9,150.74 8,723.84 7,958.72 7,157.62 5,903.24 3,646.24 Share Capital 16.48 16.47 16.47 16.43 16.36 15.49 Total Reserves 9,134.21 8,705.99 7,940.59 7,127.95 5,861.46 3,614.26 Non-Current Liabilities 457.27 488.60 89.68 93.97 80.31 80.78 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 77.66 106.54 3.26 3.82 3.93 4.07 Long Term Provisions 145.99 137.21 0.00 0.00 0.00 0.00 Current Liabilities 1,564.85 1,398.36 729.13 582.02 512.53 359.02 Trade Payables 820.41 767.75 587.35 462.85 396.35 249.09 Other Current Liabilities 619.87 520.07 109.48 76.42 62.36 81.73 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 124.56 110.54 32.30 42.75 53.82 28.20 Total Liabilities 11,172.86 10,610.80 8,777.53 7,833.61 6,496.08 4,086.04 Net Block 4,147.23 3,946.75 1,570.55 1,502.19 954.23 968.10 Gross Block 5,613.37 5,011.68 2,294.95 2,081.32 1,430.70 1,347.81 Accumulated Depreciation 1,466.14 1,064.93 724.41 579.13 476.46 379.71 Non Current Assets 4,389.91 4,965.66 1,876.73 1,981.54 1,372.44 1,239.75 Capital Work in Progress 150.56 237.88 177.22 190.75 337.81 188.47 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 87.69 119.43 128.96 286.40 77.97 81.52 Other Non Current Assets 4.43 661.59 0.00 2.21 2.43 1.66 Current Assets 6,782.94 5,645.15 6,900.81 5,852.08 5,123.64 2,846.29 Current Investments 0.00 0.00 0.00 154.87 0.00 0.00 Inventories 1,685.22 1,655.24 1,945.30 1,185.67 1,275.17 756.28 Sundry Debtors 1,516.53 1,558.69 871.39 1,074.81 670.97 601.78 Cash & Bank 2,556.21 1,839.43 3,770.68 3,093.44 3,005.75 1,325.19 Other Current Assets 1,024.98 102.61 91.00 96.75 171.75 163.03 Short Term Loans & Adv. 875.13 489.19 222.44 246.55 87.60 91.80 Net Current Assets 5,218.09 4,246.79 6,171.68 5,270.05 4,611.11 2,487.27 Total Assets 11,172.85 10,610.81 8,777.54 7,833.62 6,496.08 4,086.04

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,073.67 1,135.97 367.89 791.29 604.93 700.93 185.06 201.93 476.46 224.09 PBT 1,465.59 1,405.50 1,048.40 1,619.04 1,334.85 992.87 686.36 501.56 578.01 459.11 Adjustment -5.15 23.15 37.38 -28.19 17.30 32.15 76.12 50.94 70.69 68.72 Changes in Working Capital -34.59 23.38 -407.00 -393.05 -435.80 -79.94 -353.94 -193.43 -10.86 -187.17 Cash after chg. in Working capital 1,425.84 1,452.02 678.78 1,197.80 916.36 945.07 408.53 359.07 637.85 340.66 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -352.17 -316.05 -310.89 -406.51 -311.43 -244.14 -223.47 -157.14 -161.39 -116.56 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 1,578.20 -2,923.92 1,208.22 -1,010.23 -1,524.55 -766.08 -314.14 -358.84 -96.65 -11.91 Net Fixed Assets -140.33 -227.74 -200.10 -503.56 -232.23 -193.54 -89.41 -86.66 55.65 -209.75 Net Investments -403.83 -2,377.58 154.87 -162.48 -0.55 0.00 0.00 0.00 0.17 0.00 Others 2,122.36 -318.60 1,253.45 -344.19 -1,291.77 -572.54 -224.73 -272.18 -152.47 197.84 Cash from Financing Activity -339.54 -7.40 14.92 34.90 1,238.46 -6.87 -2.93 -3.59 -116.42 -92.90 Net Cash Inflow / Outflow 2,312.33 -1,795.35 1,591.04 -184.04 318.84 -72.01 -132.01 -160.50 263.39 119.29 Opening Cash & Equivalents 116.20 1,905.22 311.18 491.92 169.50 236.40 372.84 533.08 273.23 157.81 Closing Cash & Equivalent 2,432.62 116.20 1,905.22 311.18 491.92 169.50 236.40 372.84 533.08 273.23

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 914.73 996.80 363.97 790.77 604.93 700.93 PBT 1,062.66 1,132.54 1,054.58 1,618.55 1,334.81 992.87 Adjustment 211.94 223.60 38.19 -28.27 17.30 32.15 Changes in Working Capital -6.06 -53.20 -417.94 -393.01 -435.76 -79.94 Cash after chg. in Working capital 1,268.53 1,302.95 674.83 1,197.28 916.35 945.07 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -353.80 -306.15 -310.87 -406.51 -311.43 -244.14 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 1,704.74 -1,756.91 1,208.19 -1,002.62 -1,524.00 -766.08 Net Fixed Assets -140.33 -227.74 -200.10 -503.56 -232.23 Net Investments -403.83 -2,377.58 154.87 -162.48 -0.55 Others 2,248.90 848.41 1,253.42 -336.58 -1,291.22 Cash from Financing Activity -433.48 -799.42 14.92 34.90 1,238.46 -6.87 Net Cash Inflow / Outflow 2,185.99 -1,559.53 1,587.08 -176.95 319.39 -72.01 Opening Cash & Equivalents 357.09 1,908.89 318.82 492.46 169.50 236.40 Closing Cash & Equivalent 2,556.21 357.09 1,908.89 318.82 492.46 169.50

Financial Ratios

Standalone /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 592.08 546.04 482.80 434.87 359.30 234.25 1847.12 1555.61 1348.70 1082.33 ROA 10.92% 11.39% 9.34% 16.92% 18.84% 20.32% 14.01% 11.89% 18.15% 16.31% ROE 11.62% 12.31% 10.28% 18.62% 20.97% 23.81% 17.14% 14.27% 21.97% 20.42% ROCE 15.87% 16.67% 13.97% 24.86% 28.00% 30.68% 26.11% 22.41% 30.04% 28.35% Fixed Asset Turnover 1.53 1.71 1.65 2.51 2.49 2.05 1.80 1.58 1.47 1.47 Receivable days 102.61 89.08 97.78 72.40 67.08 76.78 87.61 100.43 94.03 69.91 Inventory Days 111.48 140.38 158.00 102.05 107.06 115.61 127.19 100.26 91.25 92.53 Payable days 70.34 87.28 113.93 74.33 96.62 73.57 99.56 79.68 57.64 32.44 Cash Conversion Cycle 143.75 142.17 141.84 100.12 77.52 118.83 115.24 121.01 127.64 129.99 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 Interest Cover 65.18 180.20 142.41 309.98 392.34 139.24 193.80 122.59 91.43 28.97

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 555.40 529.56 483.12 434.84 359.30 234.25 ROA 6.41% 7.97% 9.40% 16.91% 18.84% 18.91% ROE 7.82% 9.26% 10.34% 18.61% 20.97% 21.29% ROCE 11.97% 13.63% 14.04% 24.85% 28.00% 27.39% Fixed Asset Turnover 1.06 1.55 1.66 2.51 2.49 1.95 Receivable days 99.92 78.29 97.99 72.40 67.08 83.41 Inventory Days 108.54 116.00 157.65 102.05 107.06 104.83 Payable days 138.65 113.80 113.72 74.35 96.63 52.71 Cash Conversion Cycle 69.81 80.48 141.92 100.10 77.51 135.53 Total Debt/Equity 0.03 0.04 0.00 0.00 0.00 0.00 Interest Cover 26.30 44.23 142.61 309.77 392.33 139.24

Top Investors:

hdfc mutual fund - hdfc mid-cap fund

mirae asset large & midcap fund

nippon life india trustee ltd- a/c nippon india growth mid cap fund

sbi large & midcap fund

icici prudential india opportunities fund

government pension fund global

uti-flexi cap fund

llp

Annual Reports:

News Update:

Gland Pharma gets USFDA’s approval for Zoledronic Acid Injection
6th Feb 2026, 12:21 PM

This Product is indicated to treat Hypercalcemia of Malignancy and Multiple Myeloma and Bone Metastases of Solid Tumors
Read More
Gland Pharma - Quarterly Results
29th Jan 2026, 00:00 AM

Read More
Gland Pharma gets nod for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)
7th Jan 2026, 16:58 PM

This product is indicated for the treatment of ocular itching associated with allergic conjunctivitis
Read More

Gland Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543245 | NSE: GLAND

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Gland Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543245 | NSE: GLAND

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: